Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

A J Hughes, S E Daniel, L Kilford and A J Lees

Parkinson's Disease Society Brain Bank, Institute of Neurology, London.

Few detailed clinico-pathological correlations of Parkinson's disease have been published. The pathological findings in 100 patients diagnosed prospectively by a group of consultant neurologists as having idiopathic Parkinson's disease are reported. Seventy six had nigral Lewy bodies, and in all of these Lewy bodies were also found in the cerebral cortex. In 24 cases without Lewy bodies, diagnoses included progressive supranuclear palsy, multiple system atrophy, Alzheimer's disease, Alzheimer-type pathology, and basal ganglia vascular disease. The retrospective application of recommended diagnostic criteria improved the diagnostic accuracy to 82%. These observations call into question current concepts of Parkinson's disease as a single distinct morbid entity.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Accuracy of clinical diagnosis of idiopathic Parkinson's disease.

D R Rajput
J. Neurol. Neurosurg. Psychiatry 1993 56: 938-939. [PDF]

This article has been cited by other articles:

• Neumann, J., Bras, J., Deas, E., O'Sullivan, S. S., Parkkinen, L., Lachmann, R. H., Li, A., Holton, J., Guerreiro, R., Paudel, R., Segarane, B., Singleton, A., Lees, A., Hardy, J., Houlden, H., Revesz, T., Wood, N. W. (2009). Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain 132: 1783-1794 [Abstract] [Full Text]  
• Nichols, W. C., Kissell, D. K., Pankratz, N., Pauciulo, M. W., Elsaesser, V. E., Clark, K. A., Halter, C. A., Rudolph, A., Wojcieszek, J., Pfeiffer, R. F., Foroud, T., For the Parkinson Study Group-PROGENI Investigator, (2009). Variation in GIGYF2 is not associated with Parkinson disease. Neurology 72: 1886-1892 [Abstract] [Full Text]  
• Maks, C B, Butson, C R, Walter, B L, Vitek, J L, McIntyre, C C (2009). Deep brain stimulation activation volumes and their association with neurophysiological mapping and therapeutic outcomes. J. Neurol. Neurosurg. Psychiatry 80: 659-666 [Abstract] [Full Text]  
• Crutcher, M. D., Calhoun-Haney, R., Manzanares, C. M., Lah, J. J., Levey, A. I., Zola, S. M. (2009). Eye Tracking During a Visual Paired Comparison Task as a Predictor of Early Dementia. AM J ALZHEIMERS DIS OTHER DEMEN 24: 258-266 [Abstract]  
• Jokinen, P., Helenius, H., Rauhala, E., Bruck, A., Eskola, O., Rinne, J. O. (2009). Simple Ratio Analysis of 18F-Fluorodopa Uptake in Striatal Subregions Separates Patients with Early Parkinson Disease from Healthy Controls. JNM 50: 893-899 [Abstract] [Full Text]  
• Lee, S-T, Chu, K., Jung, K-H, Park, H-K, Kim, D-H, Bahn, J-J, Kim, J-H, Oh, M-J, Lee, S. K., Kim, M., Roh, J-K (2009). Reduced circulating angiogenic cells in Alzheimer disease. Neurology 72: 1858-1863 [Abstract] [Full Text]  
• Olanow, C. W., Stern, M. B., Sethi, K. (2009). The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology 72: S1-S136 [Abstract] [Full Text]  
• Vaillancourt, D. E., Spraker, M. B., Prodoehl, J., Abraham, I., Corcos, D. M., Zhou, X. J., Comella, C. L., Little, D. M. (2009). High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 72: 1378-1384 [Abstract] [Full Text]  
• Cilia, R., Kraff, J., Canesi, M., Pezzoli, G., Goldwurm, S., Amiri, K., Tang, H.-T., Pan, R., Hagerman, P. J., Tassone, F. (2009). Screening for the Presence of FMR1 Premutation Alleles in Women With Parkinsonism. Arch Neurol 66: 244-249 [Abstract] [Full Text]  
• Gaig, C., Marti, M. J., Ezquerra, M., Cardozo, A., Rey, M. J., Tolosa, E. (2009). G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies. BMJ Case Reports 2009: bcr0820080632-bcr0820080632 [Abstract] [Full Text]  
• Kalbe, E., Voges, J., Weber, T., Haarer, M., Baudrexel, S., Klein, J. C., Kessler, J., Sturm, V., Heiss, W. D., Hilker, R. (2009). Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease. Neurology 72: 42-49 [Abstract] [Full Text]  
• Lee, P. H., Yong, S. W., An, Y.-S. (2008). Changes in Cerebral Glucose Metabolism in Patients with Parkinson Disease with Dementia After Cholinesterase Inhibitor Therapy. JNM 49: 2006-2011 [Abstract] [Full Text]  
• Caslake, R, Moore, J N, Gordon, J C, Harris, C E, Counsell, C (2008). Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism. J. Neurol. Neurosurg. Psychiatry 79: 1202-1207 [Abstract] [Full Text]  
• Postuma, R B, Gagnon, J F, Vendette, M, Charland, K, Montplaisir, J (2008). REM sleep behaviour disorder in Parkinson's disease is associated with specific motor features. J. Neurol. Neurosurg. Psychiatry 79: 1117-1121 [Abstract] [Full Text]  
• Karimi, M., Golchin, N., Tabbal, S. D., Hershey, T., Videen, T. O., Wu, J., Usche, J. W. M., Revilla, F. J., Hartlein, J. M., Wernle, A. R., Mink, J. W., Perlmutter, J. S. (2008). Subthalamic nucleus stimulation-induced regional blood flow responses correlate with improvement of motor signs in Parkinson disease. Brain 131: 2710-2719 [Abstract] [Full Text]  
• Rizzo, G., Martinelli, P., Manners, D., Scaglione, C., Tonon, C., Cortelli, P., Malucelli, E., Capellari, S., Testa, C., Parchi, P., Montagna, P., Barbiroli, B., Lodi, R. (2008). Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain 131: 2690-2700 [Abstract] [Full Text]  
• Hilker, R., Voges, J., Weber, T., Kracht, L. W., Roggendorf, J., Baudrexel, S., Hoevels, M., Sturm, V., Heiss, W. D. (2008). STN-DBS activates the target area in Parkinson disease: An FDG-PET study. Neurology 71: 708-713 [Abstract] [Full Text]  
• Nolano, M., Provitera, V., Estraneo, A., Selim, M. M., Caporaso, G., Stancanelli, A., Saltalamacchia, A. M., Lanzillo, B., Santoro, L. (2008). Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation. Brain 131: 1903-1911 [Abstract] [Full Text]  
• Mizuno, Y., Hattori, N., Kubo, S.-i., Sato, S., Nishioka, K., Hatano, T., Tomiyama, H., Funayama, M., Machida, Y., Mochizuki, H. (2008). Progress in the pathogenesis and genetics of Parkinson's disease. Phil Trans R Soc B 363: 2215-2227 [Abstract] [Full Text]  
• Gan-Or, Z., Giladi, N., Rozovski, U., Shifrin, C., Rosner, S., Gurevich, T., Bar-Shira, A., Orr-Urtreger, A. (2008). Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology 70: 2277-2283 [Abstract] [Full Text]  
• Kumazawa, R., Tomiyama, H., Li, Y., Imamichi, Y., Funayama, M., Yoshino, H., Yokochi, F., Fukusako, T., Takehisa, Y., Kashihara, K., Kondo, T., Elibol, B., Bostantjopoulou, S., Toda, T., Takahashi, H., Yoshii, F., Mizuno, Y., Hattori, N. (2008). Mutation Analysis of the PINK1 Gene in 391 Patients With Parkinson Disease. Arch Neurol 65: 802-808 [Abstract] [Full Text]  
• Davie, C. A. (2008). A review of Parkinson's disease. Br Med Bull 86: 109-127 [Abstract] [Full Text]  
• Le Jeune, F., Peron, J., Biseul, I., Fournier, S., Sauleau, P., Drapier, S., Haegelen, C., Drapier, D., Millet, B., Garin, E., Herry, J.-Y., Malbert, C.-H., Verin, M. (2008). Subthalamic nucleus stimulation affects orbitofrontal cortex in facial emotion recognition: a pet study. Brain 131: 1599-1608 [Abstract] [Full Text]  
• Fuchs, J., Tichopad, A., Golub, Y., Munz, M., Schweitzer, K. J., Wolf, B., Berg, D., Mueller, J. C., Gasser, T. (2008). Genetic variability in the SNCA gene influences {alpha}-synuclein levels in the blood and brain. FASEB J. 22: 1327-1334 [Abstract] [Full Text]  
• Sawamoto, N., Piccini, P., Hotton, G., Pavese, N., Thielemans, K., Brooks, D. J. (2008). Cognitive deficits and striato-frontal dopamine release in Parkinson's disease. Brain 131: 1294-1302 [Abstract] [Full Text]  
• Hirano, S., Asanuma, K., Ma, Y., Tang, C., Feigin, A., Dhawan, V., Carbon, M., Eidelberg, D. (2008). Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's Disease. J. Neurosci. 28: 4201-4209 [Abstract] [Full Text]  
• Papapetropoulos, S., Jagid, J. R., Sengun, C., Singer, C., Gallo, B. V. (2008). Objective monitoring of tremor and bradykinesia during DBS surgery for Parkinson disease. Neurology 70: 1244-1249 [Abstract] [Full Text]  
• Li, Y., Grupe, A., Rowland, C., Holmans, P., Segurado, R., Abraham, R., Jones, L., Catanese, J., Ross, D., Mayo, K., Martinez, M., Hollingworth, P., Goate, A., Cairns, N. J., Racette, B. A., Perlmutter, J. S., O'Donovan, M. C., Morris, J. C., Brayne, C., Rubinsztein, D. C., Lovestone, S., Thal, L. J., Owen, M. J., Williams, J. (2008). Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. Hum Mol Genet 17: 759-767 [Abstract] [Full Text]  
• Bogdanov, M., Matson, W. R., Wang, L., Matson, T., Saunders-Pullman, R., Bressman, S. S., Beal, M. F. (2008). Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain 131: 389-396 [Abstract] [Full Text]  
• Miller, N., Noble, E., Jones, D., Allcock, L., Burn, D. J. (2008). How do I sound to me? Perceived changes in communication in Parkinson's disease. Clin Rehabil 22: 14-22 [Abstract]  
• Ahn, T. -B., Kim, S. Y., Kim, J. Y., Park, S. -S., Lee, D. S., Min, H. J.., Kim, Y. K., Kim, S. E., Kim, J. -M., Kim, H. -J., Cho, J., Jeon, B. S. (2008). {alpha}-Synuclein gene duplication is present in sporadic Parkinson disease. Neurology 70: 43-49 [Abstract] [Full Text]  
• Schestatsky, P., Kumru, H., Valls-Sole, J., Valldeoriola, F., Marti, M. J., Tolosa, E., Chaves, M. L. (2007). Neurophysiologic study of central pain in patients with Parkinson disease. Neurology 69: 2162-2169 [Abstract] [Full Text]  
• Djaldetti, R., Treves, T. A., Ziv, I., Melamed, E., Lorberboym, M. (2007). 123I-FP-CIT SPECT Imaging of Dopamine Transporters in Patients with Recurrent Sudden Falls: Are Such Falls a Distinct Entity?. J. Nucl. Med. Technol. 35: 232-236 [Abstract] [Full Text]  
• Miller, N., Allcock, L., Jones, D., Noble, E., Hildreth, A. J, Burn, D. J (2007). Prevalence and pattern of perceived intelligibility changes in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 78: 1188-1190 [Abstract] [Full Text]  
• Lee, P. H., Yeo, S. H., Yong, S. W., Kim, Y. J. (2007). Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism. J. Neurol. Neurosurg. Psychiatry 78: 1250-1252 [Abstract] [Full Text]  
• Walter, U., Dressler, D., Probst, T., Wolters, A., Abu-Mugheisib, M., Wittstock, M., Benecke, R. (2007). Transcranial Brain Sonography Findings in Discriminating Between Parkinsonism and Idiopathic Parkinson Disease. Arch Neurol 64: 1635-1640 [Abstract] [Full Text]  
• Orr-Urtreger, A., Shifrin, C., Rozovski, U., Rosner, S., Bercovich, D., Gurevich, T., Yagev-More, H., Bar-Shira, A., Giladi, N. (2007). The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: Is there a gender effect?. Neurology 69: 1595-1602 [Abstract] [Full Text]  
• Bonanni, L., Anzellotti, F., Varanese, S., Thomas, A., Manzoli, L., Onofrj, M. (2007). Delayed blink reflex in dementia with Lewy bodies. J. Neurol. Neurosurg. Psychiatry 78: 1137-1139 [Abstract] [Full Text]  
• Bronnick, K., Emre, M., Lane, R., Tekin, S., Aarsland, D. (2007). Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 78: 1064-1068 [Abstract] [Full Text]  
• Dick, F D, De Palma, G, Ahmadi, A, Scott, N W, Prescott, G J, Bennett, J, Semple, S, Dick, S, Counsell, C, Mozzoni, P, Haites, N, Wettinger, S B., Mutti, A, Otelea, M, Seaton, A, Soderkvist, P, Felice, A, on behalf of the Geoparkinson study group, (2007). Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study. Occup. Environ. Med. 64: 666-672 [Abstract] [Full Text]  
• Clark, L. N., Ross, B. M., Wang, Y., Mejia-Santana, H., Harris, J., Louis, E. D., Cote, L. J., Andrews, H., Fahn, S., Waters, C., Ford, B., Frucht, S., Ottman, R., Marder, K. (2007). Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology 69: 1270-1277 [Abstract] [Full Text]  
• Wu, Y.-R., Chen, C.-M., Chao, C.-Y., Ro, L.-S., Lyu, R.-K., Chang, K.-H., Lee-Chen, G.-J. (2007). Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese. J. Neurol. Neurosurg. Psychiatry 78: 977-979 [Abstract] [Full Text]  
• Clarke, C E (2007). Parkinson's disease. BMJ 335: 441-445 [Full Text]  
• Kas, A., Payoux, P., Habert, M.-O., Malek, Z., Cointepas, Y., El Fakhri, G., Chaumet-Riffaud, P., Itti, E., Remy, P. (2007). Validation of a Standardized Normalization Template for Statistical Parametric Mapping Analysis of 123I-FP-CIT Images. JNM 48: 1459-1467 [Abstract] [Full Text]  
• Cakit, B. D., Saracoglu, M., Genc, H., Erdem, H. R., Inan, L. (2007). The effects of incremental speed-dependent treadmill training on postural instability and fear of falling in Parkinson's disease. Clin Rehabil 21: 698-705 [Abstract]  
• Haaxma, C. A, Bloem, B. R, Borm, G. F, Oyen, W. J G, Leenders, K. L, Eshuis, S., Booij, J., Dluzen, D. E, Horstink, M. W I M (2007). Gender differences in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 78: 819-824 [Abstract] [Full Text]  
• Mondon, K, Gochard, A, Marque, A, Armand, A, Beauchamp, D, Prunier, C, Jacobi, D, de Toffol, B, Autret, A, Camus, V, Hommet, C (2007). Visual recognition memory differentiates dementia with Lewy bodies and Parkinson's disease dementia. J. Neurol. Neurosurg. Psychiatry 78: 738-741 [Abstract] [Full Text]  
• Boecker, H., Ceballos-Baumann, A. O., Volk, D., Conrad, B., Forstl, H., Haussermann, P. (2007). Metabolic Alterations in Patients With Parkinson Disease and Visual Hallucinations. Arch Neurol 64: 984-988 [Abstract] [Full Text]  
• Giladi, N., Weitzman, N., Schreiber, S., Shabtai, H., Peretz, C. (2007). New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset. J Psychopharmacol 21: 501-506 [Abstract]  
• Kraff, J., Tang, H.-T., Cilia, R., Canesi, M., Pezzoli, G., Goldwurm, S., Hagerman, P. J., Tassone, F. (2007). Screen for Excess FMR1 Premutation Alleles Among Males With Parkinsonism. Arch Neurol 64: 1002-1006 [Abstract] [Full Text]  
• Aly, N. M., Playfer, J. R., Smith, S. L., Halliday, D. M. (2007). A novel computer-based technique for the assessment of tremor in Parkinson's disease. Age Ageing 36: 395-399 [Abstract] [Full Text]  
• Walter, U., Hoeppner, J., Prudente-Morrissey, L., Horowski, S., Herpertz, S. C., Benecke, R. (2007). Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 130: 1799-1807 [Abstract] [Full Text]  
• Stoffers, D., Bosboom, J. L. W., Deijen, J. B., Wolters, E. C., Berendse, H. W., Stam, C. J. (2007). Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia. Brain 130: 1847-1860 [Abstract] [Full Text]  
• Huang, C., Tang, C., Feigin, A., Lesser, M., Ma, Y., Pourfar, M., Dhawan, V., Eidelberg, D. (2007). Changes in network activity with the progression of Parkinson's disease. Brain 130: 1834-1846 [Abstract] [Full Text]  
• Montaurier, C., Morio, B., Bannier, S., Derost, P., Arnaud, P., Brandolini-Bunlon, M., Giraudet, C., Boirie, Y., Durif, F. (2007). Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation. Brain 130: 1808-1818 [Abstract] [Full Text]  
• Storch, A., Jost, W. H., Vieregge, P., Spiegel, J., Greulich, W., Durner, J., Muller, T., Kupsch, A., Henningsen, H., Oertel, W. H., Fuchs, G., Kuhn, W., Niklowitz, P., Koch, R., Herting, B., Reichmann, H., for the German Coenzyme Q10 Study Group, (2007). Randomized, Double-blind, Placebo-Controlled Trial on Symptomatic Effects of Coenzyme Q10 in Parkinson Disease. Arch Neurol 64: 938-944 [Abstract] [Full Text]  
• Gaig, C., Marti, M. J., Ezquerra, M., Rey, M. J., Cardozo, A., Tolosa, E. (2007). G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies. J. Neurol. Neurosurg. Psychiatry 78: 626-628 [Abstract] [Full Text]  
• Grosset, D, Taurah, L, Burn, D J, MacMahon, D, Forbes, A, Turner, K, Bowron, A, Walker, R, Findley, L, Foster, O, Patel, K, Clough, C, Castleton, B, Smith, S, Carey, G, Murphy, T, Hill, J, Brechany, U, McGee, P, Reading, S, Brand, G, Kelly, L, Breen, K, Ford, S, Baker, M, Williams, A, Hearne, J, Qizilbash, N, Chaudhuri, K R. (2007). A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis. J. Neurol. Neurosurg. Psychiatry 78: 465-469 [Abstract] [Full Text]  
• Stewart, D. A. (2007). NICE guideline for Parkinson's disease. Age Ageing 36: 240-242 [Full Text]  
• Goldwurm, S., Zini, M., Mariani, L., Tesei, S., Miceli, R., Sironi, F., Clementi, M., Bonifati, V., Pezzoli, G. (2007). Evaluation of LRRK2 G2019S penetrance: Relevance for genetic counseling in Parkinson disease. Neurology 68: 1141-1143 [Abstract] [Full Text]  
• Kolevski, G., Petrov, I., Petrova, V. (2007). Transcranial Sonography in the Evaluation of Parkinson Disease. J Ultrasound Med 26: 509-512 [Abstract] [Full Text]  
• Sawamoto, N., Honda, M., Hanakawa, T., Aso, T., Inoue, M., Toyoda, H., Ishizu, K., Fukuyama, H., Shibasaki, H. (2007). Cognitive slowing in Parkinson disease is accompanied by hypofunctioning of the striatum. Neurology 68: 1062-1068 [Abstract] [Full Text]  
• Gantois, I., Fang, K., Jiang, L., Babovic, D., Lawrence, A. J., Ferreri, V., Teper, Y., Jupp, B., Ziebell, J., Morganti-Kossmann, C. M., O'Brien, T. J., Nally, R., Schutz, G., Waddington, J., Egan, G. F., Drago, J. (2007). Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior. Proc. Natl. Acad. Sci. USA 104: 4182-4187 [Abstract] [Full Text]  
• Papapetropoulos, S., Tuchman, A., Laufer, D., Papatsoris, A. G, Papapetropoulos, N., Mash, D. C (2007). Causes of death in multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 78: 327-329 [Full Text]  
• Kramer, M. L., Schulz-Schaeffer, W. J. (2007). Presynaptic {alpha}-Synuclein Aggregates, Not Lewy Bodies, Cause Neurodegeneration in Dementia with Lewy Bodies. J. Neurosci. 27: 1405-1410 [Abstract] [Full Text]  
• Nieuwboer, A, Kwakkel, G, Rochester, L, Jones, D, van Wegen, E, Willems, A M, Chavret, F, Hetherington, V, Baker, K, Lim, I (2007). Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial. J. Neurol. Neurosurg. Psychiatry 78: 134-140 [Abstract] [Full Text]  
• De Cock, V. C., Vidailhet, M., Leu, S., Texeira, A., Apartis, E., Elbaz, A., Roze, E., Willer, J. C., Derenne, J. P., Agid, Y., Arnulf, I. (2007). Restoration of normal motor control in Parkinson's disease during REM sleep. Brain 130: 450-456 [Abstract] [Full Text]  
• Scherzer, C. R., Eklund, A. C., Morse, L. J., Liao, Z., Locascio, J. J., Fefer, D., Schwarzschild, M. A., Schlossmacher, M. G., Hauser, M. A., Vance, J. M., Sudarsky, L. R., Standaert, D. G., Growdon, J. H., Jensen, R. V., Gullans, S. R. (2007). Molecular markers of early Parkinson's disease based on gene expression in blood. Proc. Natl. Acad. Sci. USA 104: 955-960 [Abstract] [Full Text]  
• Dick, S., Semple, S., Dick, F., Seaton, A. (2007). Occupational titles as risk factors for Parkinson's disease. Occup Med (Lond) 57: 50-56 [Abstract] [Full Text]  
• Blain, C.R.V., Barker, G. J., Jarosz, J. M., Coyle, N. A., Landau, S., Brown, R. G., Chaudhuri, K. R., Simmons, A., Jones, D. K., Williams, S. C.R., Leigh, P. N. (2006). Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI. Neurology 67: 2199-2205 [Abstract] [Full Text]  
• Hiner, B. C. (2006). Differential Diagnosis of Parkinson's Disease: A New Blood Test?. Clin Med Res 4: 246-247 [Full Text]  
• Pellecchia, M. T., Pivonello, R., Colao, A., Barone, P. (2006). Growth Hormone Stimulation Tests in the Differential Diagnosis of Parkinson's Disease. Clin Med Res 4: 322-325 [Abstract] [Full Text]  
• Papapetropoulos, S., Lieberman, A., Gonzalez, J., Singer, C., Laufer, D. Z., Mash, D. C. (2006). Family history of dementia: dementia with lewy bodies and dementia in Parkinson's disease.. J. Neuropsychiatry Clin. Neurosi. 18: 113-116 [Abstract] [Full Text]  
• Clark, L. N., Wang, Y., Karlins, E., Saito, L., Mejia-Santana, H., Harris, J., Louis, E. D., Cote, L. J., Andrews, H., Fahn, S., Waters, C., Ford, B., Frucht, S., Ottman, R., Marder, K. (2006). Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology 67: 1786-1791 [Abstract] [Full Text]  
• Pavese, N., Evans, A. H., Tai, Y. F., Hotton, G., Brooks, D. J., Lees, A. J., Piccini, P. (2006). Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study.. Neurology 67: 1612-1617 [Abstract] [Full Text]  
• Sim, C. H., Lio, D. S. S., Mok, S. S., Masters, C. L., Hill, A. F., Culvenor, J. G., Cheng, H.-C. (2006). C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Hum Mol Genet 15: 3251-3262 [Abstract] [Full Text]  
• McNamara, P., Durso, R., Harris, E. (2006). Life goals of patients with Parkinson's disease: a pilot study on correlations with mood and cognitive functions. Clin Rehabil 20: 818-826 [Abstract]  
• Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schafer, H., Botzel, K., Daniels, C., Deutschlander, A., Dillmann, U., Eisner, W., Gruber, D., Hamel, W., Herzog, J., Hilker, R., Klebe, S., Kloss, M., Koy, J., Krause, M., Kupsch, A., Lorenz, D., Lorenzl, S., Mehdorn, H. M., Moringlane, J. R., Oertel, W., Pinsker, M. O., Reichmann, H., Reuss, A., Schneider, G.-H., Schnitzler, A., Steude, U., Sturm, V., Timmermann, L., Tronnier, V., Trottenberg, T., Wojtecki, L., Wolf, E., Poewe, W., Voges, J., the German Parkinson Study Group, Neurostimulation, (2006). A randomized trial of deep-brain stimulation for Parkinson's disease.. NEJM 355: 896-908 [Abstract] [Full Text]  
• Seppi, K., Scherfler, C., Donnemiller, E., Virgolini, I., Schocke, M. F. H., Goebel, G., Mair, K. J., Boesch, S., Brenneis, C., Wenning, G. K., Poewe, W. (2006). Topography of Dopamine Transporter Availability in Progressive Supranuclear Palsy: A Voxelwise [123I]beta-CIT SPECT Analysis.. Arch Neurol 63: 1154-1160 [Abstract] [Full Text]  
• Plaha, P., Ben-Shlomo, Y., Patel, N. K., Gill, S. S. (2006). Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain 129: 1732-1747 [Abstract] [Full Text]  
• Sharma, M, Mueller, J C, Zimprich, A, Lichtner, P, Hofer, A, Leitner, P, Maass, S, Berg, D, Durr, A, Bonifati, V, De Michele, G, Oostra, B, Brice, A, Wood, N W, Muller-Myhsok, B, Gasser, T, European Consortium on Genetic Susceptibility in P, (2006). The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populations. J. Med. Genet. 43: 557-562 [Abstract] [Full Text]  
• Taylor, K. S M, Counsell, C. (2006). Is it Parkinson's disease, and if not, what is it?. PN 6: 154-165 [Full Text]  
• Spiegel, J., Hellwig, D., Mollers, M.-O., Behnke, S., Jost, W., Fassbender, K., Samnick, S., Dillmann, U., Becker, G., Kirsch, C.-M. (2006). Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease. Brain 129: 1188-1193 [Abstract] [Full Text]  
• Suchowersky, O., Reich, S., Perlmutter, J., Zesiewicz, T., Gronseth, G., Weiner, W. J. (2006). Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.. Neurology 66: 968-975 [Abstract] [Full Text]